+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anemia Drugs Market by Drug Class (Erythropoiesis Stimulating Agents, Folic Acid And B12, Iron Supplements), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Route Of Administration, End User - Global Forecast 2025-2030- Product Image
Anemia Drugs Market by Drug Class (Erythropoiesis Stimulating Agents, Folic Acid And B12, Iron Supplements), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Route Of Administration, End User - Global Forecast 2025-2030- Product Image
Sale

Anemia Drugs Market by Drug Class (Erythropoiesis Stimulating Agents, Folic Acid And B12, Iron Supplements), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Route Of Administration, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5887703
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global anemia drugs market is experiencing accelerated growth as healthcare providers, pharmaceutical leaders, and policymakers align on the need for innovative, effective anemia treatments. Evolving therapeutic approaches and the integration of advanced technologies are redefining care standards and enabling stakeholders to address previously unmet patient needs.

Market Snapshot: Strategic Momentum in the Global Anemia Drugs Market

The anemia drugs market grew from USD 21.24 billion in 2024 to USD 23.70 billion in 2025. Projected to expand at a CAGR of 11.14%, the sector is expected to reach USD 40.04 billion by 2030, reflecting robust investment and ongoing scientific innovation. Drivers include rising global prevalence of anemia linked to nutritional deficiencies, chronic diseases, and genetic disorders. Heightened focus on next-generation biologics, targeted therapies, and advanced iron formulations is shaping a dynamic and competitive landscape. Strategic partnerships, digitized monitoring solutions, and a recalibrated regulatory environment further support sustained growth and market expansion.

Scope & Segmentation: Primary Growth Drivers and Market Breakdown

  • Drug Class: Includes erythropoiesis stimulating agents such as darbepoetin alfa, epoetin alfa, and epoetin beta; folic acid and B12 therapies like cyanocobalamin and folic acid; and iron supplements such as ferrous gluconate, ferrous sulfate, iron dextran, and iron sucrose.
  • Distribution Channel: Hospital pharmacies, online pharmacies, and retail pharmacies each deliver unique access routes, balancing acute care with broad outpatient reach and rising telehealth demand.
  • Route of Administration: Market offerings encompass both intravenous and oral formulations, supporting tailored treatment for diverse patient needs and settings.
  • End User: Hospitals, clinics, and home care providers serve as focal points in therapy administration, with the latter gaining increased importance for maintenance and chronic management.
  • Geographic Coverage: Key growth opportunities are mapped across the Americas (noting the United States, Canada, Mexico, Brazil, Argentina, and major U.S. states); Europe, Middle East & Africa (including the United Kingdom, Germany, France, Russia, Italy, and others); and Asia-Pacific (with China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, and Taiwan highlighted).
  • Innovative Technologies: New modalities include engineered erythropoietin analogs, long-acting biologics, oral iron nanoparticles, hypoxia-inducible factor stabilizers, and digital health integration for remote monitoring and adherence tracking.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Anemia drug innovation is progressing rapidly through investment in advanced biologics, targeted therapies, and biomarker-driven patient stratification.
  • Emerging markets and evolving payer expectations are reshaping research priorities and commercialization tactics, driving the adoption of biosimilars and locally developed therapies.
  • Digitization in care delivery, with telehealth and online pharmacies, is enhancing patient adherence and supporting evidence-based outcomes.
  • Strategic alliances between large pharma, mid-size biotech, and academic research organizations are accelerating the pace of pipeline development and product differentiation.
  • Market segmentation by distribution channel and administration route supports tailored approaches for acute, chronic, and maintenance populations.
  • Regulatory shifts, especially regarding expedited approvals for breakthrough therapies, are shortening commercialization timelines and requiring adaptive R&D strategies.

Tariff Impact: Navigating Cost Structures and Global Supply Chains

Recent tariff revisions in the United States have triggered recalibration in supply chain strategies for raw materials and finished anemia drug formulations. Increased duties on key ingredients have prompted multinational firms to diversify procurement, invest in domestic manufacturing, and enhance traceability through blockchain and IoT-enabled systems. While large manufacturers have improved supply chain resilience, smaller companies face tighter margins and have explored strategic mergers or alliances. Complexities in payer negotiations and the move toward value-based contracting further underscore the impact of shifting trade policies.

Methodology & Data Sources: Ensuring Integrity and Analytical Rigor

This analysis draws upon primary research, including interviews with clinical experts, regulatory specialists, supply chain executives, and payers, supplemented by secondary sources such as peer-reviewed journals, regulatory filings, and proprietary databases. Findings underwent multi-source validation and cross-verification, with scenario analysis employed to assess the effects of regulatory and technological changes. All methodological steps are documented to ensure transparency and repeatability.

Anemia Drugs Market: Why This Report Matters

  • Enables executives to formulate data-driven strategies and prioritize investment in high-growth segments within the anemia drugs sector.
  • Provides actionable intelligence on adapting product portfolios, navigating tariff-related challenges, and optimizing distribution in a rapidly changing regulatory landscape.
  • Equips decision-makers with insights into regional dynamics and technology trends shaping current and future therapy adoption.

Conclusion

The anemia drugs market is on a decisive growth path, driven by technological advances, regulatory change, and strategic collaboration. Stakeholders leveraging comprehensive market intelligence are positioned for competitive advantage and long-term value creation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of intravenous iron therapies in chronic kidney disease patients
5.2. Expansion of oral hypoxia-inducible factor prolyl hydroxylase inhibitors for chronic kidney disease-related anemia
5.3. Increase in personalized erythropoiesis-stimulating agent dosing using genomic biomarkers
5.4. Growing interest in comparative efficacy of iron sucrose versus ferric carboxymaltose in dialysis patients
5.5. Advancements in long-acting erythropoietin formulations aimed at reducing injection frequency in patients
5.6. Emergence of biosimilar erythropoiesis-stimulating agents driving pricing competition in developed markets
5.7. Investment surge in next-generation oral chelators targeting iron overload management in thalassemia patients
5.8. Integration of digital health monitoring tools for real-time anemia treatment adherence and patient outcomes tracking
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Anemia Drugs Market, by Drug Class
8.1. Introduction
8.2. Erythropoiesis Stimulating Agents
8.2.1. Darbepoetin Alfa
8.2.2. Epoetin Alfa
8.2.3. Epoetin Beta
8.3. Folic Acid And B12
8.3.1. Cyanocobalamin
8.3.2. Folic Acid
8.4. Iron Supplements
8.4.1. Ferrous Gluconate
8.4.2. Ferrous Sulfate
8.4.3. Iron Dextran
8.4.4. Iron Sucrose
9. Anemia Drugs Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy
10. Anemia Drugs Market, by Route Of Administration
10.1. Introduction
10.2. Intravenous
10.3. Oral
11. Anemia Drugs Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Care
11.4. Hospitals
12. Americas Anemia Drugs Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Anemia Drugs Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Anemia Drugs Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Amgen Inc.
15.3.2. F. Hoffmann-La Roche Ltd.
15.3.3. Johnson & Johnson
15.3.4. Vifor (International) AG
15.3.5. Takeda Pharmaceutical Company Limited
15.3.6. Pfizer Inc.
15.3.7. Kyowa Kirin Co., Ltd.
15.3.8. Fresenius Kabi AG
15.3.9. Novartis AG
15.3.10. CSL Limited
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ANEMIA DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANEMIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANEMIA DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANEMIA DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANEMIA DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ANEMIA DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ANEMIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. ANEMIA DRUGS MARKET: RESEARCHAI
FIGURE 24. ANEMIA DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 25. ANEMIA DRUGS MARKET: RESEARCHCONTACTS
FIGURE 26. ANEMIA DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANEMIA DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANEMIA DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANEMIA DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANEMIA DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANEMIA DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANEMIA DRUGS MARKET SIZE, BY DARBEPOETIN ALFA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANEMIA DRUGS MARKET SIZE, BY DARBEPOETIN ALFA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANEMIA DRUGS MARKET SIZE, BY EPOETIN ALFA, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANEMIA DRUGS MARKET SIZE, BY EPOETIN ALFA, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANEMIA DRUGS MARKET SIZE, BY EPOETIN BETA, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANEMIA DRUGS MARKET SIZE, BY EPOETIN BETA, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANEMIA DRUGS MARKET SIZE, BY CYANOCOBALAMIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANEMIA DRUGS MARKET SIZE, BY CYANOCOBALAMIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANEMIA DRUGS MARKET SIZE, BY FERROUS GLUCONATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANEMIA DRUGS MARKET SIZE, BY FERROUS GLUCONATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANEMIA DRUGS MARKET SIZE, BY FERROUS SULFATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANEMIA DRUGS MARKET SIZE, BY FERROUS SULFATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANEMIA DRUGS MARKET SIZE, BY IRON DEXTRAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANEMIA DRUGS MARKET SIZE, BY IRON DEXTRAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANEMIA DRUGS MARKET SIZE, BY IRON SUCROSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANEMIA DRUGS MARKET SIZE, BY IRON SUCROSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANEMIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANEMIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANEMIA DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANEMIA DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANEMIA DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANEMIA DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANEMIA DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANEMIA DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANEMIA DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANEMIA DRUGS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANEMIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANEMIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ANEMIA DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ANEMIA DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ANEMIA DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ANEMIA DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ANEMIA DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ANEMIA DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ANEMIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ANEMIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 95. CANADA ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 96. CANADA ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 97. CANADA ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 98. CANADA ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 99. CANADA ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2018-2024 (USD MILLION)
TABLE 100. CANADA ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2025-2030 (USD MILLION)
TABLE 101. CANADA ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 102. CANADA ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 103. CANADA ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. CANADA ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. CANADA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 106. CANADA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 107. CANADA ANEMIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. CANADA ANEMIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. MEXICO ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 110. MEXICO ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 111. MEXICO ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 112. MEXICO ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 113. MEXICO ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2018-2024 (USD MILLION)
TABLE 114. MEXICO ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2025-2030 (USD MILLION)
TABLE 115. MEXICO ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 116. MEXICO ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 117. MEXICO ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. MEXICO ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. MEXICO ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 120. MEXICO ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 121. MEXICO ANEMIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. MEXICO ANEMIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL ANEMIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL ANEMIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA ANEMIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA ANEMIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM ANEMIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM ANEMIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. GERMANY ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 182. GERMANY ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 183. GERMANY ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 184. GERMANY ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 185. GERMANY ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2018-2024 (USD MILLION)
TABLE 186. GERMANY ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2025-2030 (USD MILLION)
TABLE 187. GERMANY ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 188. GERMANY ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 189. GERMANY ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. GERMANY ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. GERMANY ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 192. GERMANY ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 193. GERMANY ANEMIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. GERMANY ANEMIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. FRANCE ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 196. FRANCE ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 197. FRANCE ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 198. FRANCE ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 199. FRANCE ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2018-2024 (USD MILLION)
TABLE 200. FRANCE ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2025-2030 (USD MILLION)
TABLE 201. FRANCE ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 202. FRANCE ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 203. FRANCE ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. FRANCE ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. FRANCE ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 206. FRANCE ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 207. FRANCE ANEMIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. FRANCE ANEMIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA ANEMIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA ANEMIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. ITALY ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 224. ITALY ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 225. ITALY ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 226. ITALY ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 227. ITALY ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2018-2024 (USD MILLION)
TABLE 228. ITALY ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2025-2030 (USD MILLION)
TABLE 229. ITALY ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 230. ITALY ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 231. ITALY ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. ITALY ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. ITALY ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 234. ITALY ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 235. ITALY ANEMIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. ITALY ANEMIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. SPAIN ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 238. SPAIN ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 239. SPAIN ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 240. SPAIN ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 241. SPAIN ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2018-2024 (USD MILLION)
TABLE 242. SPAIN ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2025-2030 (USD MILLION)
TABLE 243. SPAIN ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 244. SPAIN ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 245. SPAIN ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. SPAIN ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. SPAIN ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 248. SPAIN ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 249. SPAIN ANEMIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. SPAIN ANEMIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES ANEMIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES ANEMIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA ANEMIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA ANEMIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA ANEMIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. SOUTH AFRICA ANEMIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. DENMARK ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 294. DENMARK ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 295. DENMARK ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 296. DENMARK ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 297. DENMARK ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2018-2024 (USD MILLION)
TABLE 298. DENMARK ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2025-2030 (USD MILLION)
TABLE 299. DENMARK ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 300. DENMARK ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 301. DENMARK ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. DENMARK ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. DENMARK ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 304. DENMARK ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 305. DENMARK ANEMIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. DENMARK ANEMIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. NETHERLANDS ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 318. NETHERLANDS ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 319. NETHERLANDS ANEMIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. NETHERLANDS ANEMIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321. QATAR ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 322. QATAR ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 323. QATAR ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 324. QATAR ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 325. QATAR ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2018-2024 (USD MILLION)
TABLE 326. QATAR ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2025-2030 (USD MILLION)
TABLE 327. QATAR ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 328. QATAR ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 329. QATAR ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 330. QATAR ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 331. QATAR ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 332. QATAR ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 333. QATAR ANEMIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 334. QATAR ANEMIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 335. FINLAND ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 336. FINLAND ANEMIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 337. FINLAND ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 338. FINLAND ANEMIA DRUGS MARKET SIZE, BY ERYTHROPOIESIS STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 339. FINLAND ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2018-2024 (USD MILLION)
TABLE 340. FINLAND ANEMIA DRUGS MARKET SIZE, BY FOLIC ACID AND B12, 2025-2030 (USD MILLION)
TABLE 341. FINLAND ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 342. FINLAND ANEMIA DRUGS MARKET SIZE, BY IRON SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 343. FINLAND ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 344. FINLAND ANEMIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 345. FINLAND ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 346. FINLAND ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 347. FINLAND ANEMIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 348. FINLAND ANEMIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
T

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Anemia Drugs market report include:
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Vifor (International) AG
  • Takeda Pharmaceutical Company Limited
  • Pfizer Inc.
  • Kyowa Kirin Co., Ltd.
  • Fresenius Kabi AG
  • Novartis AG
  • CSL Limited

Table Information

Report AttributeDetails
No. of Pages181
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 23.7 Billion
Forecasted Market Value ( USD ) by 2030 $ 40.04 Billion
Compound Annual Growth Rate11.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Anti-anemia Drugs Market by Drug Class (Blood Transfusion, Erythropoiesis Stimulating Agents, Iron Preparations), Route Of Administration (Intravenous, Oral, Subcutaneous), Distribution Channel, End User, Patient Demographics - Global Forecast 2025-2030 - Product Image

Anti-anemia Drugs Market by Drug Class (Blood Transfusion, Erythropoiesis Stimulating Agents, Iron Preparations), Route Of Administration (Intravenous, Oral, Subcutaneous), Distribution Channel, End User, Patient Demographics - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Anemia Drugs Global Market Report 2025 - Product Image

Anemia Drugs Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Anemia Drugs - Global Strategic Business Report - Product Image

Anemia Drugs - Global Strategic Business Report

  • Report
  • 383 Pages
  • Global
From
Renal Anemia Drug Pipeline Analysis Report 2025 - Product Image

Renal Anemia Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • 200 Pages
  • Global
From
Fanconi Anemia (FA) - Pipeline Insight, 2025 - Product Image

Fanconi Anemia (FA) - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From

About the Anemia Drug Market

The Anemia Drug market is a subset of the larger Hematological Drugs market, which includes drugs used to treat blood-related diseases. Anemia drugs are used to treat anemia, a condition in which the body does not produce enough healthy red blood cells. These drugs can be used to treat a variety of anemias, including iron deficiency anemia, aplastic anemia, and sickle cell anemia. Anemia drugs can be administered orally, intravenously, or intramuscularly, depending on the type of anemia being treated. Common anemia drugs include erythropoietin, darbepoetin, and epoetin alfa. Erythropoietin is a hormone that stimulates the production of red blood cells, while darbepoetin and epoetin alfa are synthetic versions of erythropoietin. Other anemia drugs include iron supplements, folic acid, and vitamin B12. Some companies in the Anemia Drug market include Amgen, Johnson & Johnson, Novartis, Pfizer, and Roche. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.